Waldenstrom Macroglobulinemia Latest Advances
Find the Latest Research About Waldenstrom Macroglobulinemia
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6709 publications
PROTAC degraders for lymphoid malignancies - current status and future directions.
Journal: Expert opinion on emerging drugs
Published: October 23, 2026
Treatment of Waldenström macroglobulinemia associated with AL amyloidosis with teclistamab: a case report.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: October 05, 2026
Pneumocystis Jirovecii Pneumonia Associated with Prolonged CD4-positive T-cell Depletion after Bendamustine-Rituximab Therapy: A Case Report.
Journal: Internal medicine (Tokyo, Japan)
Published: September 30, 2026
Uveitis as a class effect of Bruton tyrosine kinase inhibitors: ibrutinib and zanubrutinib ocular toxicity.
Journal: BMJ case reports
Published: September 29, 2026
Current and new approaches to the treatment landscape for adults with Waldenström macroglobulinemia.
Current and new approaches to the treatment landscape for adults with Waldenström macroglobulinemia.
Journal: Expert opinion on pharmacotherapy
Published: September 16, 2026
Cost-effectiveness of zanubrutinib versus ibrutinib as first-line treatment for patients with Waldenström macroglobulinemia in China.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: September 10, 2026
Lymphoplasmacytic Lymphoma Involving Marrow-Containing Submandibular Heterotopic Ossification: A Case Report and Literature Review.
Journal: Head and neck pathology
Published: September 01, 2026
Ibrutinib as the Unifying Culprit: A Case Report of Multisystem Complications in an Elderly Patient With Low-Grade B-Cell Lymphoproliferative Disorder.
Journal: Cureus
Published: August 30, 2026
IgM Pleural Amyloidosis Diagnosed by Pleural Effusion Cell Block: A Case Report.
Journal: Internal medicine (Tokyo, Japan)
Published: August 10, 2026
Clinical Characteristics and Prognosis of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 03, 2026
Mechanisms of resistance to BTK inhibitors in B cell malignancies and emerging targeted strategies.
Journal: Molecular therapy. Oncology
Published: July 28, 2026
Last Updated: 11/08/2026